Clinical Trial Update: Topical Ruxolitinib in Chronic Hand Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial of topical ruxolitinib for chronic hand dermatitis with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Dermatitis

Drugs mentioned

• Ruxolitinib (topical) (ruxolitinib)

Snippet

Sponsor: University of Rochester | Conditions: Chronic Hand Dermatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-10-15